🇺🇸 FDA
Patent

US 7417037

Compositions and methods of treatment for inflammatory diseases

granted A61KA61K31/13A61K31/198

Quick answer

US patent 7417037 (Compositions and methods of treatment for inflammatory diseases) held by The Board of Regents of the University of Oklahoma expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/13, A61K31/198, A61K31/355, A61K31/375